Modifiable Risk Factors and Atrial Fibrillation

Circulation

Volumn 136, Issue 6, 2017, Pages 583-596

  Lau, Dennis H ^a   Nattel, Stanley ^b,c   Kalman, Jonathan M ^d   Sanders, Prashanthan ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

atrial fibrillation; cardiorespiratory fitness; obesity; physiopathology; risk factors; weight loss

Indexed keywords

ANTICOAGULANT AGENT;

AGING; ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; CATHETER ABLATION; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; HUMAN; HYPERTENSION; LIFESTYLE; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SINUS RHYTHM; SLEEP DISORDERED BREATHING; VALVULAR HEART DISEASE; ANIMAL; COMPLICATION; DIABETIC COMPLICATION; MORTALITY; PATHOLOGY;

ANIMALS; ATRIAL FIBRILLATION; DIABETES COMPLICATIONS; HUMANS; HYPERTENSION; LIFE STYLE; OBESITY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 85026922589     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.023163     Document Type: Review

References (99)

1. Patel NJ, Deshmukh A, Pant S, Singh V, Patel N, Arora S, Shah N, Chothani A, Savani GT, Mehta K, Parikh V, Rathod A, Badheka AO, Lafferty J, Kowalski M, Mehta JL, Mitrani RD, Viles-Gonzalez JF, Paydak H. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: Implications for healthcare planning. Circulation. 2014;129:2371-2379. doi: 10.1161/CIRCULATIONAHA.114.008201.
2. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study. Circulation. 2014;129:837-847. doi: 10.1161/CIRCULATIONAHA.113.005119.
3. Gupta A, Perera T, Ganesan A, Sullivan T, Lau DH, Roberts-Thomson KC, Brooks AG, Sanders P. Complications of catheter ablation of atrial fibrillation: A systematic review. Circ Arrhythm Electrophysiol. 2013;6:1082-1088. doi: 10.1161/CIRCEP.113.000768.
4. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130:2071-2104. doi: 10.1161/CIR.0000000000000040.
5. Link MS, Haïssaguerre M, Natale A. Ablation of atrial fibrillation: Patient selection, periprocedural anticoagulation, techniques, and preventive measures after ablation. Circulation. 2016;134:339-352. doi: 10.1161/CIRCULATIONAHA.116.021727.
6. Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS, Sullivan T, Roberts-Thomson KC, Sanders P. Long-term outcomes of catheter ablation of atrial fibrillation: A systematic review and meta-analysis. J Am Heart Assoc. 2013;2:e004549. doi: 10.1161/JAHA.112.004549.
7. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TS, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: Report from a national heart, lung, and blood institute workshop. Circulation. 2009;119:606-618. doi: 10.1161/CIRCULATIONAHA.108.825380.
8. Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, Van Gelder IC, Halle M, Kudaiberdieva G, Lane DA, Larsen TB, Lip GY, Løchen ML, Marín F, Niebauer J, Sanders P, Tokgozoglu L, Vos MA, Van Wagoner DR, Fauchier L, Savelieva I, Goette A, Agewall S, Chiang CE, Figueiredo M, Stiles M, Dickfeld T, Patton K, Piepoli M, Corra U, Marques-Vidal PM, Faggiano P, Schmid JP, Abreu A; EHRA Scientific Committee Task Force; Document reviewers. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2017;19:190-225. doi: 10.1093/europace/euw242.
9. Malmo V, Nes BM, Amundsen BH, Tjonna AE, Stoylen A, Rossvoll O, Wisloff U, Loennechen JP. Aerobic interval training reduces the burden of atrial fibrillation in the short term: A randomized trial. Circulation. 2016;133:466-473. doi: 10.1161/CIRCULATIONAHA.115.018220.
10. Mohanty S, Mohanty P, Di Biase L, Bai R, Trivedi C, Santangeli P, Santoro F, Hongo R, Hao S, Beheiry S, Burkhardt D, Gallinghouse JG, Horton R, Sanchez JE, Bailey S, Hranitzky PM, Zagrodzky J, Natale A. Long-term outcome of catheter ablation in atrial fibrillation patients with coexistent metabolic syndrome and obstructive sleep apnea: Impact of repeat proce dures versus lifestyle changes. J Cardiovasc Electrophysiol. 2014;25:930-938. doi: 10.1111/jce.12468.
11. Pathak RK, Elliott A, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Hendriks JM, Twomey D, Kalman JM, Abhayaratna WP, Lau DH, Sanders P. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study. J Am Coll Cardiol. 2015;66:985-996. doi: 10.1016/j.jacc.2015.06.488.
12. Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, Kalman JM, Abhayaratna WP, Sanders P. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: The ARREST-AF cohort study. J Am Coll Cardiol. 2014;64:2222-2231. doi: 10.1016/j.jacc.2014.09.028.
13. Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, Twomey D, Elliott AD, Kalman JM, Abhayaratna WP, Lau DH, Sanders P. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: A long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65:2159-2169. doi: 10.1016/j.jacc.2015.03.002.
14. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840-844.
15. Rangnekar G. The characterisation of risk factors, substrate and management strategies for atrial fibrillation [dissertation]. School of Medicine, The University of Adelaide; 2015.
16. Jamaly S, Carlsson L, Peltonen M, Jacobson P, Sjöström L, Karason K. Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects. J Am Coll Cardiol. 2016;68:2497-2504. doi: 10.1016/j. jacc.2016.09.940.
17. Alonso A, Bahnson JL, Gaussoin SA, Bertoni AG, Johnson KC, Lewis CE, Vetter M, Mantzoros CS, Jeffery RW, Soliman EZ; Look AHEAD Research Group. Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: The Look AHEAD randomized trial. Am Heart J. 2015;170:770-777.e5. doi: 10.1016/j.ahj.2015.07.026
18. Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, Maclehose R, Konety S, Alonso A. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: The Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123:1501-1508. doi: 10.1161/CIRCULATIONAHA.110.009035.
19. Chamberlain AM, Agarwal SK, Ambrose M, Folsom AR, Soliman EZ, Alonso A. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2010;159:850-856. doi: 10.1016/j.ahj.2010.02.005.
20. Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG, D'Agostino RB Sr, Kannel WB, Levy D, Benjamin EJ. Pulse pressure and risk of new-onset atrial fibrillation. JAMA. 2007;297:709-715. doi: 10.1001/jama.297.7.709.
21. Stevenson IH, Teichtahl H, Cunnington D, Ciavarella S, Gordon I, Kalman JM. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J. 2008;29:1662-1669. doi: 10.1093/eurheartj/ehn214.
22. Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, Somers VK. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49:565-571. doi: 10.1016/j.jacc.2006.08.060
23. Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, Al-Mallah MH. Cardiorespiratory fitness and risk of incident atrial fibrillation: Results from the Henry Ford Exercise Testing (FIT) Project. Circulation. 2015;131:1827-1834. doi: 10.1161/CIRCULATIONAHA.114.014833.
24. Huxley RR, Misialek JR, Agarwal SK, Loehr LR, Soliman EZ, Chen LY, Alonso A. Physical activity, obesity, weight change, and risk of atrial fibrillation: The Atherosclerosis Risk in Communities study. Circ Arrhythm Electrophysiol. 2014;7:620-625. doi: 10.1161/CIRCEP.113.001244.
25. Calvo N, Ramos P, Montserrat S, Guasch E, Coll-Vinent B, Domenech M, Bisbal F, Hevia S, Vidorreta S, Borras R, Falces C, Embid C, Montserrat JM, Berruezo A, Coca A, Sitges M, Brugada J, Mont L. Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: A prospective case-control study. Europace. 2016;18:57-63. doi: 10.1093/europace/euv216.
26. Tucker NR, Ellinor PT. Emerging directions in the genetics of atrial fibrillation. Circ Res. 2014;114:1469-1482. doi: 10.1161/CIRCRESAHA. 114.302225.
27. Kim EJ, Yin X, Fontes JD, Magnani JW, Lubitz SA, McManus DD, Seshadri S, Vasan RS, Ellinor PT, Larson MG, Benjamin EJ, Rienstra M. Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study). Am Heart J. 2016;177:138-144. doi: 10.1016/j.ahj.2016.03.023.
28. Wyse DG, Van Gelder IC, Ellinor PT, Go AS, Kalman JM, Narayan SM, Nattel S, Schotten U, Rienstra M. Lone atrial fibrillation: Does it exist J Am Coll Cardiol. 2014;63:1715-1723. doi: 10.1016/j.jacc.2014.01.023.
29. Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: Relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114:1453-1468. doi: 10.1161/CIRCRESAHA.114.303211.
30. Heijman J, Algalarrondo V, Voigt N, Melka J, Wehrens XH, Dobrev D, Nattel S. The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: A critical analysis. Cardiovasc Res. 2016;109:467-479. doi: 10.1093/cvr/cvv275.
31. Takahashi K, Sasano T, Sugiyama K, Kurokawa J, Tamura N, Soejima Y, Sawabe M, Isobe M, Furukawa T. High-fat diet increases vulnerability to atrial arrhythmia by conduction disturbance via miR-27b. J Mol Cell Cardiol. 2016;90:38-46. doi: 10.1016/j.yjmcc.2015.11.034.
32. Okumura Y, Watanabe I, Nagashima K, Sonoda K, Sasaki N, Kogawa R, Takahashi K, Iso K, Ohkubo K, Nakai T, Takahashi R, Taniguchi Y, Mitsumata M, Nikaido M, Hirayama A. Effects of a high-fat diet on the electrical properties of porcine atria. J Arrhythm. 2015;31:352-358. doi: 10.1016/j. joa.2015.05.004.
33. Iwasaki YK, Shi Y, Benito B, Gillis MA, Mizuno K, Tardif JC, Nattel S. Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea. Heart Rhythm. 2012;9:1409-16.e1. doi: 10.1016/j. hrthm.2012.03.024.
34. Mahajan R, Lau DH, Brooks AG, Shipp NJ, Manavis J, Wood JP, Finnie JW, Samuel CS, Royce SG, Twomey DJ, Thanigaimani S, Kalman JM, Sanders P. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol. 2015;66:1-11. doi: 10.1016/j.jacc.2015.04.058.
35. Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, Mahajan R, Kuklik P, Zhang Y, Brooks AG, Nelson AJ, Worthley SG, Abhayaratna WP, Kalman JM, Wittert GA, Sanders P. Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation. Heart Rhythm. 2013;10:90-100. doi: 10.1016/j.hrthm.2012.08.043.
36. Lin YK, Chen YC, Chang SL, Lin YJ, Chen JH, Yeh YH, Chen SA, Chen YJ. Heart failure epicardial fat increases atrial arrhythmogenesis. Int J Cardiol. 2013;167:1979-1983. doi: 10.1016/j.ijcard.2012.05.009.
37. Lin YK, Chen YC, Chen JH, Chen SA, Chen YJ. Adipocytes modulate the electrophysiology of atrial myocytes: Implications in obesity-induced atrial fibrillation. Basic Res Cardiol. 2012;107:293. doi: 10.1007/s00395-012-0293-1.
38. Iwasaki YK, Kato T, Xiong F, Shi YF, Naud P, Maguy A, Mizuno K, Tardif JC, Comtois P, Nattel S. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol. 2014;64:2013-2023. doi: 10.1016/j.jacc.2014.05.077.
39. Stevenson IH, Roberts-Thomson KC, Kistler PM, Edwards GA, Spence S, Sanders P, Kalman JM. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: Implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm. 2010;7:1263-1270. doi: 10.1016/j.hrthm.2010.03.020.
40. Linz D, Schotten U, Neuberger HR, Böhm M, Wirth K. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm. 2011;8:1436-1443. doi: 10.1016/j. hrthm.2011.03.053.
41. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, Böhm M. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60:172-178. doi: 10.1161/HYPERTENSIONAHA.112.191965.
42. Linz D, Hohl M, Nickel A, Mahfoud F, Wagner M, Ewen S, Schotten U, Maack C, Wirth K, Böhm M. Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension. 2013;62:767-774. doi: 10.1161/HYPERTENSIONAHA. 113.01728.
43. Gao M, Zhang L, Scherlag BJ, Huang B, Stavrakis S, Hou YM, Hou Y, Po SS. Low-level vagosympathetic trunk stimulation inhibits atrial fibrillation in a rabbit model of obstructive sleep apnea. Heart Rhythm. 2015;12:818-824. doi: 10.1016/j.hrthm.2014.12.024.
44. Zhao J, Xu W, Yun F, Zhao H, Li W, Gong Y, Yuan Y, Yan S, Zhang S, Ding X, Wang D, Zhang C, Dong D, Xiu C, Yang N, Liu L, Xue J, Li Y. Chronic obstructive sleep apnea causes atrial remodeling in canines: Mechanisms and implications. Basic Res Cardiol. 2014;109:427. doi: 10.1007/s00395-014-0427-8.
45. Ghias M, Scherlag BJ, Lu Z, Niu G, Moers A, Jackman WM, Lazzara R, Po SS. The role of ganglionated plexi in apnea-related atrial fibrillation. J Am Coll Cardiol. 2009;54:2075-2083. doi: 10.1016/j.jacc.2009.09.014.
46. Okazaki H, Minamino T, Tsukamoto O, Kim J, Okada K, Myoishi M, Wakeno M, Takashima S, Mochizuki N, Kitakaze M. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Hypertens Res. 2006;29:277-284. doi: 10.1291/hypres.29.277.
47. Kim SJ, Choisy SC, Barman P, Zhang H, Hancox JC, Jones SA, James AF. Atrial remodeling and the substrate for atrial fibrillation in rat hearts with elevated afterload. Circ Arrhythm Electrophysiol. 2011;4:761-769. doi: 10.1161/CIRCEP.111.964783.
48. Pluteanu F, Hes J, Plackic J, Nikonova Y, Preisenberger J, Bukowska A, Schotten U, Rinne A, Kienitz MC, Schäfer MK, Weihe E, Goette A, Kockskämper J. Early subcellular Ca2+ remodelling and increased propensity for Ca2+ alternans in left atrial myocytes from hypertensive rats. Cardiovasc Res. 2015;106:87-97. doi: 10.1093/cvr/cvv045.
49. Lau DH, Shipp NJ, Kelly DJ, Thanigaimani S, Neo M, Kuklik P, Lim HS, Zhang Y, Drury K, Wong CX, Chia NH, Brooks AG, Dimitri H, Saint DA, Brown L, Sanders P. Atrial arrhythmia in ageing spontaneously hypertensive rats: Unraveling the substrate in hypertension and ageing. PLoS One. 2013;8:e72416. doi: 10.1371/journal.pone.0072416.
50. Kistler PM, Sanders P, Dodic M, Spence SJ, Samuel CS, Zhao C, Charles JA, Edwards GA, Kalman JM. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: Implications for development of atrial fibrillation. Eur Heart J. 2006;27:3045-3056. doi: 10.1093/eurheartj/ehl360.
51. Lau DH, Mackenzie L, Kelly DJ, Psaltis PJ, Brooks AG, Worthington M, Rajendram A, Kelly DR, Zhang Y, Kuklik P, Nelson AJ, Wong CX, Worthley SG, Rao M, Faull RJ, Edwards J, Saint DA, Sanders P. Hypertension and atrial fibrillation: Evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model. Heart Rhythm. 2010;7:1282-1290. doi: 10.1016/j. hrthm.2010.05.010.
52. Lau DH, Mackenzie L, Kelly DJ, Psaltis PJ, Worthington M, Rajendram A, Kelly DR, Nelson AJ, Zhang Y, Kuklik P, Brooks AG, Worthley SG, Faull RJ, Rao M, Edwards J, Saint DA, Sanders P. Short-term hypertension is associated with the development of atrial fibrillation substrate: A study in an ovine hypertensive model. Heart Rhythm. 2010;7:396-404. doi: 10.1016/j.hrthm.2009.11.031.
53. Mitasíková M, Lin H, Soukup T, Imanaga I, Tribulová N. Diabetes and thyroid hormones affect connexin-43 and PKC-epsilon expression in rat heart atria. Physiol Res. 2009;58:211-217.
54. Kato T, Yamashita T, Sekiguchi A, Tsuneda T, Sagara K, Takamura M, Kaneko S, Aizawa T, Fu LT. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat. J Cardiovasc Electrophysiol. 2008;19:415-420. doi: 10.1111/j.1540-8167.2007.01037.x.
55. Liu C, Fu H, Li J, Yang W, Cheng L, Liu T, Li G. Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits. Anadolu Kardiyol Derg. 2012;12:543-550. doi: 10.5152/akd.2012.188.
56. Fu H, Liu C, Li J, Zhou C, Cheng L, Liu T, Li G. Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits. Cardiol J. 2013;20:59-67. doi: 10.5603/CJ.2013.0010.
57. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: Mechanisms and implications. Circ Arrhythm Electrophysiol. 2008;1:62-73. doi: 10.1161/CIRCEP.107.754564.
58. Lau DH, Schotten U, Mahajan R, Antic NA, Hatem SN, Pathak RK, Hendriks JM, Kalman JM, Sanders P. Novel mechanisms in the pathogenesis of atrial fibrillation: Practical applications. Eur Heart J. 2016;37:1573-1581. doi: 10.1093/eurheartj/ehv375.
59. Hatem SN, Sanders P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res. 2014;102:205-213. doi: 10.1093/cvr/cvu045.
60. Fenelon G, Balbaõ CE, Fernandes R, Arfelli E, Landim P, Ayres O, Paola AA. Characterization of the acute cardiac electrophysiologic effects of ethanol in dogs. Alcohol Clin Exp Res. 2007;31:1574-1580. doi: 10.1111/j.1530-0277.2007.00451.x.
61. Laszlo R, Eick C, Schwiebert M, Schreiner B, Weig HJ, Weretka S, Bosch RF, Schreieck J. Alcohol-induced electrical remodeling: Effects of sustained short-term ethanol infusion on ion currents in rabbit atrium. Alcohol Clin Exp Res. 2009;33:1697-1703. doi: 10.1111/j.1530-0277.2009.01006.x.
62. Chen YC, Chen SA, Chen YJ, Tai CT, Chan P, Lin CI. Effect of ethanol on the electrophysiological characteristics of pulmonary vein cardiomyocytes. Eur J Pharmacol. 2004;483:215-222.
63. Guasch E, Benito B, Qi X, Cifelli C, Naud P, Shi Y, Mighiu A, Tardif JC, Tadevosyan A, Chen Y, Gillis MA, Iwasaki YK, Dobrev D, Mont L, Heximer S, Nattel S. Atrial fibrillation promotion by endurance exercise: Demonstration and mechanistic exploration in an animal model. J Am Coll Cardiol. 2013;62:68-77. doi: 10.1016/j.jacc.2013.01.091.
64. Kistler PM, Sanders P, Fynn SP, Stevenson IH, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol. 2004;44:109-116. doi: 10.1016/j.jacc.2004.03.044.
65. Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Electrical remodeling of the atria in congestive heart failure: Electrophysiological and electroanatomic mapping in humans. Circulation. 2003;108:1461-1468. doi: 10.1161/01.CIR.0000090688.49283.67.
66. Medi C, Kalman JM, Spence SJ, Teh AW, Lee G, Bader I, Kaye DM, Kistler PM. Atrial electrical and structural changes associated with longstanding hypertension in humans: Implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22:1317-1324. doi: 10.1111/j.1540-8167.2011.02125.x.
67. Dimitri H, Ng M, Brooks AG, Kuklik P, Stiles MK, Lau DH, Antic N, Thornton A, Saint DA, McEvoy D, Antic R, Kalman JM, Sanders P. Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation. Heart Rhythm. 2012;9:321-327. doi: 10.1016/j.hrthm.2011.10.017.
68. Munger TM, Dong YX, Masaki M, Oh JK, Mankad SV, Borlaug BA, Asirvatham SJ, Shen WK, Lee HC, Bielinski SJ, Hodge DO, Herges RM, Buescher TL, Wu JH, Ma C, Zhang Y, Chen PS, Packer DL, Cha YM. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60:851-860. doi: 10.1016/j.jacc.2012.03.042.
69. Stiles MK, John B, Wong CX, Kuklik P, Brooks AG, Lau DH, Dimitri H, Roberts-Thomson KC, Wilson L, De Sciscio P, Young GD, Sanders P. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: Characterizing the "second factor." J Am Coll Cardiol. 2009;53:1182-1191. doi: 10.1016/j.jacc.2008.11.054.
70. Proietti R, Hadjis A, AlTurki A, Thanassoulis G, Roux J-F, Verma A, Healey JS, Bernier ML, Birnie D, Nattel S, Essebag V. A systematic review on the progression of paroxysmal to persistent atrial fibrillation shedding new light on the effects of catheter ablation. JACC Clin Electrophysiol. 2015;1:105-115.
71. Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, Boone J, Sheldon R, Dorian P, Newman D. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation. Am Heart J. 2005;149:489-496. doi: 10.1016/j.ahj.2004.09.053.
72. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, van den Heijkant AC, Allessie MA, Crijns HJ. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol. 2010;55:725-731. doi: 10.1016/j.jacc.2009.11.040.
73. Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, Morton JB, Sanders P, Kalman JM. Long-term effects of catheter ablation for lone atrial fibrillation: Progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm. 2012;9:473-480. doi: 10.1016/j. hrthm.2011.11.013.
74. Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Heart Rhythm. 2015;12:681-686. doi: 10.1016/j. hrthm.2014.12.034.
75. Mohanty S, Mohanty P, Di Biase L, Bai R, Pump A, Santangeli P, Burkhardt D, Gallinghouse JG, Horton R, Sanchez JE, Bailey S, Zagrodzky J, Natale A. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J Am Coll Cardiol. 2012;59:1295-1301. doi: 10.1016/j.jacc.2011.11.051.
76. Wong CX, Sullivan T, Sun MT, Mahajan R, Pathak RK, Middeldorp M, Twomey D, Ganesan AN, Rangnekar G, Roberts-Thomson KC, Lau DH, Sanders P. Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation. JACC Clini Electrophysiol. 2015;1:139-152.
77. Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G, Leong DP, Lau DH, Middeldorp ME, Roberts-Thomson KC, Wittert GA, Abhayaratna WP, Worthley SG, Sanders P. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57:1745-1751. doi: 10.1016/j.jacc.2010.11.045.
78. Ng CY, Liu T, Shehata M, Stevens S, Chugh SS, Wang X. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol. 2011;108:47-51. doi: 10.1016/j. amjcard.2011.02.343.
79. Khaykin Y, Oosthuizen R, Zarnett L, Essebag V, Parkash R, Seabrook C, Beardsall M, Tsang B, Wulffhart Z, Verma A. Clinical predictors of arrhythmia recurrences following pulmonary vein antrum isolation for atrial fibrillation: Predicting arrhythmia recurrence post-PVAI. J Cardiovasc Electrophysiol. 2011;22:1206-1214. doi: 10.1111/j.1540-8167.2011.02108.x
80. Steinberg JS, Palekar R, Sichrovsky T, Arshad A, Preminger M, Musat D, Shaw RE, Mittal S. Very long-term outcome after initially successful catheter ablation of atrial fibrillation. Heart Rhythm. 2014;11:771-776. doi: 10.1016/j.hrthm.2014.02.003.
81. Lau DH, Middeldorp ME, Brooks AG, Ganesan AN, Roberts-Thomson KC, Stiles MK, Leong DP, Abed HS, Lim HS, Wong CX, Willoughby SR, Young GD, Kalman JM, Abhayaratna WP, Sanders P. Aortic stiffness in lone atrial fibrillation: A novel risk factor for arrhythmia recurrence. PLoS One. 2013;8:e76776. doi: 10.1371/journal.pone.0076776.
82. Lu ZH, Liu N, Bai R, Yao Y, Li SN, Yu RH, Sang CH, Tang RB, Long DY, Du X, Dong JZ, Ma CS. HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation. Herz. 2015;40(suppl 2):130-136. doi: 10.1007/s00059-014-4154-6.
83. Qiao Y, Shi R, Hou B, Wu L, Zheng L, Ding L, Chen G, Zhang S, Yao Y. Impact of alcohol consumption on substrate remodeling and ablation outcome of paroxysmal atrial fibrillation. J Am Heart Assoc. 2015;4:e002349.
84. Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, Lorimer MF, Lau DH, Antic NA, Brooks AG, Abhayaratna WP, Kalman JM, Sanders P. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: A randomized clinical trial. JAMA. 2013;310:2050-2060. doi: 10.1001/jama.2013.280521.
85. Li L, Wang ZW, Li J, Ge X, Guo LZ, Wang Y, Guo WH, Jiang CX, Ma CS. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: A meta-analysis of observational studies. Europace. 2014;16:1309-1314. doi: 10.1093/europace/euu066.
86. Müller P, Grabowski C, Schiedat F, Shin DI, Dietrich JW, Mügge A, Deneke T, Walther JW, Kara K. Reverse remodelling of the atria after treatment of obstructive sleep apnoea with continuous positive airway pressure: Evidence from electro-mechanical and endocrine markers. Heart Lung Circ. 2016;25:53-60. doi: 10.1016/j.hlc.2015.05.004.
87. Thomas MC, Dublin S, Kaplan RC, Glazer NL, Lumley T, Longstreth WT Jr, Smith NL, Psaty BM, Siscovick DS, Heckbert SR. Blood pressure control and risk of incident atrial fibrillation. Am J Hypertens. 2008;21:1111-1116. doi: 10.1038/ajh.2008.248.
88. Okin PM, Hille DA, Larstorp AC, Wachtell K, Kjeldsen SE, Dahlöf B, Devereux RB. Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients. Hypertension. 2015;66:368-373. doi: 10.1161/HYPERTENSIONAHA.115.05728.
89. Schaer BA, Schneider C, Jick SS, Conen D, Osswald S, Meier CR. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: A nested case-control study. Ann Intern Med. 2010;152:78-84. doi: 10.7326/0003-4819-152-2-201001190-00005.
90. Marott SC, Nielsen SF, Benn M, Nordestgaard BG. Antihypertensive treatment and risk of atrial fibrillation: A nationwide study. Eur Heart J. 2014;35:1205-1214. doi: 10.1093/eurheartj/eht507.
91. Emdin CA, Callender T, Cao J, Rahimi K. Effect of antihypertensive agents on risk of atrial fibrillation: A meta-analysis of large-scale randomized trials. Europace. 2015;17:701-710. doi: 10.1093/europace/euv021.
92. Pokushalov E, Romanov A, Katritsis DG, Artyomenko S, Bayramova S, Losik D, Baranova V, Karaskov A, Steinberg JS. Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: Early experience. Heart Rhythm. 2014;11:1131-1138. doi: 10.1016/j.hrthm.2014.03.055.
93. Pathak RK, Evans M, Middeldorp ME, Mahajan R, Mehta AB, Meredith M, Twomey D, Wong CX, Hendriks JML, Abhayaratna WP, Kalman JM, Lau DH, Sanders P. Cost-effectiveness and clinical effectiveness of the risk factor management clinic in atrial fibrillation. JACC Clin Electrophysiol. 2017;3:436-447.
94. Hendriks JM, de Wit R, Crijns HJ, Vrijhoef HJ, Prins MH, Pisters R, Pison LA, Blaauw Y, Tieleman RG. Nurse-led care vs. usual care for patients with atrial fibrillation: Results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J. 2012;33:2692-2699. doi: 10.1093/eurheartj/ehs071.
95. Stewart S, Ball J, Horowitz JD, Marwick TH, Mahadevan G, Wong C, Abhayaratna WP, Chan YK, Esterman A, Thompson DR, Scuffham PA, Carrington MJ. Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: Pragmatic, multicentre, randomised controlled trial. Lancet. 2015;385:775-784. doi: 10.1016/S0140-6736(14)61992-9.
96. Carter L, Gardner M, Magee K, Fearon A, Morgulis I, Doucette S, Sapp JL, Gray C, Abdelwahab A, Parkash R. An integrated management approach to atrial fibrillation. J Am Heart Assoc. 2016;5:e002950.
97. Lowres N, Neubeck L, Freedman SB, Briffa T, Bauman A, Redfern J. Lifestyle risk reduction interventions in atrial fibrillation: A systematic review. Eur J Prev Cardiol. 2012;19:1091-1100. doi: 10.1177/1741826711422505.
98. Reed JL, Mark AE, Reid RD, Pipe AL. The effects of chronic exercise training in individuals with permanent atrial fibrillation: A systematic review. Can J Cardiol. 2013;29:1721-1728. doi: 10.1016/j.cjca.2013.09.020.
99. La Gerche A. The potential cardiotoxic effects of exercise. Can J Cardiol. 2016;32:421-428. doi: 10.1016/j.cjca.2015.11.010.